scholarly journals Artificial intelligence and colorectal cancer: How far can you go?

2021 ◽  
Vol 2 (2) ◽  
pp. 7-11
Author(s):  
Rita Alloro ◽  
Emanuele Sinagra
2020 ◽  
Vol 9 (10) ◽  
pp. 3313 ◽  
Author(s):  
Hemant Goyal ◽  
Rupinder Mann ◽  
Zainab Gandhi ◽  
Abhilash Perisetti ◽  
Aman Ali ◽  
...  

Globally, colorectal cancer is the third most diagnosed malignancy. It causes significant mortality and morbidity, which can be reduced by early diagnosis with an effective screening test. Integrating artificial intelligence (AI) and computer-aided detection (CAD) with screening methods has shown promising colorectal cancer screening results. AI could provide a “second look” for endoscopists to decrease the rate of missed polyps during a colonoscopy. It can also improve detection and characterization of polyps by integration with colonoscopy and various advanced endoscopic modalities such as magnifying narrow-band imaging, endocytoscopy, confocal endomicroscopy, laser-induced fluorescence spectroscopy, and magnifying chromoendoscopy. This descriptive review discusses various AI and CAD applications in colorectal cancer screening, polyp detection, and characterization.


2020 ◽  
Author(s):  
Sijun Meng ◽  
Yueping Zheng ◽  
Ruizhang Su ◽  
Wangyue Wang ◽  
Yu Zhang ◽  
...  

ABSTRACTColorectal cancer (CRC) is the third in incidence and mortality1 of cancer. Screening with colonoscopy has been shown to reduce mortality by 40-60%2. Challenge for screening indistinguishable precancerous and noninvasive lesion using conventional colonoscopy was still existing3. We propose to establish a propagable artificial intelligence assisted high malignant potential early CRC characterization system (ECRC-CAD). 4,390 endoscopic images of early CRC were used to establish the model. The diagnostic accuracy of high malignant potential early CRC was 0.963 (95% CI, 0.941-0.978) in the internal validation set and 0.835 (95% CI, 0.805-0.862) in external datasets. It achieved better performance than the expert endoscopists. Spreading of ECRC-CAD to regions with different medical levels can assist in CRC screening and prevention.


2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Tenghui Han ◽  
Jun Zhu ◽  
Xiaoping Chen ◽  
Rujie Chen ◽  
Yu Jiang ◽  
...  

Abstract Background Liver is the most common metastatic site of colorectal cancer (CRC) and liver metastasis (LM) determines subsequent treatment as well as prognosis of patients, especially in T1 patients. T1 CRC patients with LM are recommended to adopt surgery and systematic treatments rather than endoscopic therapy alone. Nevertheless, there is still no effective model to predict the risk of LM in T1 CRC patients. Hence, we aim to construct an accurate predictive model and an easy-to-use tool clinically. Methods We integrated two independent CRC cohorts from Surveillance Epidemiology and End Results database (SEER, training dataset) and Xijing hospital (testing dataset). Artificial intelligence (AI) and machine learning (ML) methods were adopted to establish the predictive model. Results A total of 16,785 and 326 T1 CRC patients from SEER database and Xijing hospital were incorporated respectively into the study. Every single ML model demonstrated great predictive capability, with an area under the curve (AUC) close to 0.95 and a stacking bagging model displaying the best performance (AUC = 0.9631). Expectedly, the stacking model exhibited a favorable discriminative ability and precisely screened out all eight LM cases from 326 T1 patients in the outer validation cohort. In the subgroup analysis, the stacking model also demonstrated a splendid predictive ability for patients with tumor size ranging from one to50mm (AUC = 0.956). Conclusion We successfully established an innovative and convenient AI model for predicting LM in T1 CRC patients, which was further verified in the external dataset. Ultimately, we designed a novel and easy-to-use decision tree, which only incorporated four fundamental parameters and could be successfully applied in clinical practice.


Endoscopy ◽  
2018 ◽  
Vol 50 (03) ◽  
pp. C2-C2 ◽  
Author(s):  
Katsuro Ichimasa ◽  
Shin-ei Kudo ◽  
Yuichi Mori ◽  
Masashi Misawa ◽  
Shingo Matsudaira ◽  
...  

2021 ◽  
Vol 27 (38) ◽  
pp. 6399-6414
Author(s):  
Michelle Viscaino ◽  
Javier Torres Bustos ◽  
Pablo Muñoz ◽  
Cecilia Auat Cheein ◽  
Fernando Auat Cheein

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sergei Bedrikovetski ◽  
Nagendra N. Dudi-Venkata ◽  
Hidde M. Kroon ◽  
Warren Seow ◽  
Ryash Vather ◽  
...  

Abstract Background Artificial intelligence (AI) is increasingly being used in medical imaging analysis. We aimed to evaluate the diagnostic accuracy of AI models used for detection of lymph node metastasis on pre-operative staging imaging for colorectal cancer. Methods A systematic review was conducted according to PRISMA guidelines using a literature search of PubMed (MEDLINE), EMBASE, IEEE Xplore and the Cochrane Library for studies published from January 2010 to October 2020. Studies reporting on the accuracy of radiomics models and/or deep learning for the detection of lymph node metastasis in colorectal cancer by CT/MRI were included. Conference abstracts and studies reporting accuracy of image segmentation rather than nodal classification were excluded. The quality of the studies was assessed using a modified questionnaire of the QUADAS-2 criteria. Characteristics and diagnostic measures from each study were extracted. Pooling of area under the receiver operating characteristic curve (AUROC) was calculated in a meta-analysis. Results Seventeen eligible studies were identified for inclusion in the systematic review, of which 12 used radiomics models and five used deep learning models. High risk of bias was found in two studies and there was significant heterogeneity among radiomics papers (73.0%). In rectal cancer, there was a per-patient AUROC of 0.808 (0.739–0.876) and 0.917 (0.882–0.952) for radiomics and deep learning models, respectively. Both models performed better than the radiologists who had an AUROC of 0.688 (0.603 to 0.772). Similarly in colorectal cancer, radiomics models with a per-patient AUROC of 0.727 (0.633–0.821) outperformed the radiologist who had an AUROC of 0.676 (0.627–0.725). Conclusion AI models have the potential to predict lymph node metastasis more accurately in rectal and colorectal cancer, however, radiomics studies are heterogeneous and deep learning studies are scarce. Trial registration PROSPERO CRD42020218004.


Sign in / Sign up

Export Citation Format

Share Document